Literature DB >> 27884246

Anticoagulant-Related Nephropathy: Is an AKI Elephant Hiding in Plain View?

Sergey V Brodsky1, Lee A Hebert2.   

Abstract

Entities:  

Keywords:  acute kidney injury; atrial fibrillation; direct thrombin inhibitor; warfarin

Mesh：

Substances：

Year:  2016        PMID： 27884246     DOI： 10.1016/j.jacc.2016.09.926

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  11 in total

1.  Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.

Authors:  Jung-Im Shin; Shengyuan Luo; G Caleb Alexander; Lesley A Inker; Josef Coresh; Alex R Chang; Morgan E Grams
Journal:  J Am Coll Cardiol       Date:  2018-01-16       Impact factor: 24.094

2.  The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.

Authors:  Justyna Domienik-Karłowicz; Olga Tronina; Wojciech Lisik; Magdalena Durlik; Piotr Pruszczyk
Journal:  Cardiol J       Date:  2019-03-26       Impact factor: 2.737

3.  Under-recognized post-stroke acute kidney injury: risk factors and relevance for stroke outcome of a frequent comorbidity.

Authors:  Fabrizio Grosjean; Michela Tonani; Rosario Maccarrone; Carlo Cerra; Federica Spaltini; Annalisa De Silvestri; Francesco Falaschi; Simona Migliazza; Carmine Tinelli; Teresa Rampino; Antonio Di Sabatino; Alessandra Martignoni
Journal:  Int Urol Nephrol       Date:  2019-06-20       Impact factor: 2.370

4.  IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy.

Authors:  Hernando Trujillo; Justo Sandino; Teresa Cavero; Fernando Caravaca-Fontán; Eduardo Gutiérrez; Ángel M Sevillano; Amir Shabaka; Gema Fernández-Juárez; Pablo Rodríguez Doyágüez; Rocío Gimena Muñoz; Leonardo Calle García; Virginia Cabello; José Manuel Muñoz-Terol; Ana García Santiago; Oscar Toldos; Juan Antonio Moreno; Manuel Praga
Journal:  Kidney Int Rep       Date:  2022-01-19

5.  Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study.

Authors:  Siavash Piran; Hugh Traquair; Noel Chan; Marlene Robinson; Sam Schulman
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

Review 6.  Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2018-06-12       Impact factor: 4.546

7.  Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury.

Authors:  Chih-Chung Shiao; Wei-Chih Kan; Jian-Jhong Wang; Yu-Feng Lin; Likwang Chen; Eric Chueh; Ya-Ting Huang; Wen-Po Chiang; Li-Jung Tseng; Chih-Hsien Wang; Vin-Cent Wu
Journal:  J Clin Med       Date:  2018-08-29       Impact factor: 4.241

8.  Bioptically Proven "Anticoagulation-Related Nephropathy" Induced by Dual Antiplatelet Therapy.

Authors:  Karolína Krátká; Martin Havrda; Eva Honsová; Ivan Rychlík
Journal:  Case Rep Nephrol Dial       Date:  2018-10-02

9.  Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin.

Authors:  Rocco A Montone; Giampaolo Niccoli; Vincenzo Tufaro; Silvia Minelli; Michele Russo; Federico Vergni; Luigi Sommariva; Francesco Pelliccia; Francesco Bedogni; Filippo Crea
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-04-04       Impact factor: 1.426

10.  Association of latent class analysis-derived subphenotypes of acute kidney injury with mortality in critically ill patients with cardiovascular disease: a retrospective cohort study.

Authors:  Yongqing Huang; Zhanchao Xiao; Yong Xie; Shaoxin Zheng; Taihui Yu; Zhixuan Guo; Dan Su; Anqi Song; Yangxin Chen; Shuxian Zhou; Qi Guo; Jingfeng Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-04-07       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.